After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...

RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

Alternative to Meds Center has expanded its educational resources on Caplyta side effects. Whenever a newer medication ...

Published in the journal Endoscopy, the study compared two non-surgical obesity treatments in 150 adults treated between January 2024 and April 2025.

RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney ...

Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, ...

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical ...

Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...

By examining immune activity directly in the lungs, researchers uncovered three pneumotypes that may explain why patients ...